Status:
COMPLETED
Coughing at Time of Cervical Biopsy
Lead Sponsor:
Zydolab - Institute of Cytology and Immune Cytochemistry
Conditions:
Cervical Cancer
Cervical Dysplasia
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
To investigate the effect of coughing as an intervention to reduce pain in colposcopy guided biopsy.
Detailed Description
Colposcopy is a frequently practiced examination and Colposcopy guided biopsy causes pain. A few trials Investigated whether medical interventions such as the application of lidocaine led to reduced p...
Eligibility Criteria
Inclusion
- Completed 18 years of age
- written informed consent
- first colposcopy
- Clinically indicated colposcopy in case of an abnormal PAP smear or screening result and/or clinical abnormalities on the cervix uteri
- Necessity to take exactly two biopsies
Exclusion
- Performing only one biopsy or more than two biopsies
- Performing an endocervical curettage (biopsy on the endocervix)
- Vaginal bleeding at the time of examination
- inadequate colposcopy
- Cervix uteri cannot be fully visualized
- Pregnancy
- Patients with insufficient German language skills
- known anxiety disorders or depressive disorders
- Treatments already carried out on the cervix uteri
- Patients with a chronic or acute illness that influences the perception of pain or lead to permanent pain due to the disease itself
- psychosomatic illnesses
- Chronic use of pain medications or psychotropic medications or other medications that may have an influence on the sensation of pain
Key Trial Info
Start Date :
January 2 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06149598
Start Date
January 2 2024
End Date
May 30 2024
Last Update
March 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zydolab - Institute of Cytology and Immune Cytochemistry
Dortmund, North Rhine-Westphalia, Germany, 44137